NCT06046794View on ClinicalTrials.gov

Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

May 23, 2024

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2027

Conditions

Cancer Of Pancreas

Interventions

OTHER

Analyze of GemCore status

Genomic analyze of GemCore status

Trial Locations (1)

Unknown

RECRUITING

Institut Paoli Calmettes, Marseille

All Listed Sponsors

lead

Institut Paoli-Calmettes

OTHER